Prevalence of polycystic ovaries among patients with hirsutism and menstrual abnormalities
Keywords:
Polycystic ovaries, oligomenorrhea, oligohypomenorrhea, hirsutismAbstract
Background Polycystic ovaries are considered to be the most frequent cause of hirsutism with its prevalence of 10% of woman of reproductive age group. Polycystic ovarian syndrome (PCOS) reflects multiple potential etiologies and variable clinical presentations Objectives To investigate the prevalence of polycystic ovaries among patients with hirsutism and menstrual abnormalities (oligo- or oligohypomenorrhea) and to correlate presence of hirsutism with BMI, polycystic ovaries, ovarian volume and biochemical markers. Patients and methods All patients who presented with oligo- or oligohypomenorrhea or hirsutism either in outpatient clinic of Obstetrics and Gynecology, Shalamar Hospital or a private laser clinic were enrolled in study. Patients who had hirsutism with normal menstrual cycle were excluded from study. Enrolled patients were categorized into two groups on basis of hirsutism, group 1: oligomenorrhea/oligohypomenorrhea with hirsutism and group 2: oligomenorrhea/oligohypomenorrhea without hirsutism. A detailed clinical history, clinical examination, hormonal profile and abdominopelvic ultrasound were done in all patients. SPSS version 16 was used for statistical analysis. Results Out of 90 patients who enrolled in the study, 10 did not report back, so were excluded from study. Out of 80 patients with menstrual problem, 55 (68.7%) had hirsutism (group 1) and 25 (31.3%) had no hirsutism (group 2). Prevalence of polycystic ovaries was 815% among patients with hirsutism and oligo/oligohypomenorrhea (group 1) as compared to 44% in patients with oligo/oligohypomenorrhea without hirsutism (group 2). Ovarian volume >10ml and BMI were not statistically significant among both groups. Regarding hormonal profile, serum LH/FSH ratio and testosterone levels were significant among patients with hirsutism as compared to without hirsutism. Conclusion Prevalence of polycystic ovaries by morphology, FSH/LH ratio and serum testosterone are significantly present among patients with oligo/oligohypomenorrhea and hirsutism as compared to those with oligo/oligohypomennorhea without hirsutism. However Ovarian volume and BMI are not statistically significant among both groups.References
Ahmad QM, Shah JH, Sameen F et al. Hirsutism in Kashmir: an etiological study. Indian J Dermatol2009: 54: 80-2.
Glintborg D, Andersen M. An Update of the pathogenesis, inflammation and metabolism in hirsutism and polycystic ovarian syndrome. Gynecol Endocrinol 2010; 26: 281-96.
Stowitzki T, Capp E, von Eye Corleta H. The degree of cycle irregularity correlates with grade of endocrine and metabolic disorders in PCOS patients. Eur J Obstet Gynaecol Reprod Biol 2010; 149: 178-81.
Shayya R, Chang RJ. Reproductive endocrinology of adolescent polycystic ovary syndrome. Br J Obstet Gynaecol 2010; 117: 150-5.
Somani N, Harrison S, Bergfeld WF. The clinical evaluation of hirsutism. Dermatol Ther 2008; 21: 376-91.
Taponen S, Ahonkallio S, Martikalnen H et al. Prevalence of polycystic ovaries with self reported symptoms of oligomenorrhea and/or hirsutism. Nother Finland Birth Cohort 1966 Study. Human Repro 2004; 19: 1083-8.
Rehman-Ur-F, Sohail I, Hayat Z, Niazi NA. Etiology of hirsutism. Is there a correlation between menstrual regularity, body mass index and severity of hirsutism with the cause? J Pak Assoc Dermatol 2010; 20: 4-8.
Rasenfield RL. What every physician should know about polycystic ovary syndrome. Dermatol Ther 2008; 21: 354-61.
Moreira S, Soares E, Tomaz G et al. Polycystic ovary syndrome; a psychosocial approach. Acta Med Port 2010; 23: 237-42.
Dewailly D, Heironimus S, Mirakian P, Hugues JN. Polycystic ovary syndrome (PCOS). Ann Endocrinol 2010; 71: 8-13.
Hassa H, Tanir HM, Yildiz Z. Comparison of clinical and laboratory characteristic of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical sign are oligo/anovulation or hirsutism. Arch Gynecol Obstet 2006; 274: 227-32.
Alexender CJ, Tangchitnob EP, Lepor NE. Polycystic ovary syndrome: a major unrecognised cardiovascular risk factor in women. Rev Obstet Gynaecol 2009; 2: 232-9.
Guasetella E, Longo RA, Crmina E. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril 2010; 94: 2197-201.
Brodell LA, Mercurio MG. Hirsutism: Diagnosis and management. Gend Med 2010; 7: 79-87.
Pugeat M, Dechaud H, Raverot V et al. Recommendation for investigation of hyperandrogenism. Ann Endocrinol 2010; 71: 2-7.
Sharquie KE, Al-Bayatti AA, Al-Ajeel AI et al. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestation in patients with polycystic ovary syndrome. Saudi Med J 2007; 28: 1039-43.